Dinger Suanluo Shaping Jiaonang (丁二酸洛沙平胶囊)丁二酸洛沙平胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

丁二酸洛沙平是一种在国家药监局注册认定的药品。标注生产企业为海正辉瑞制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司、海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司、海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 丁二酸洛沙平胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 海正辉瑞制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司, 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司, 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 丁二酸洛沙平胶囊Recorded Chinese name: 丁二酸洛沙平胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 13.6mg×30片13.6 mg × 30 tablets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 海正辉瑞制药有限公司Chinese legal name: 海正辉瑞制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20056302

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20056302

Manufacturer

Chinese legal name: 海正辉瑞制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

13.6 mg × 30 tablets

中文说明书原文Original Chinese source label

批准文号

国药准字H20056302

生产企业

海正辉瑞制药有限公司(国产)

适应症

本品用于精神分裂症。

用法用量

本品口服:开始剂量为每日34-68mg(1-2粒),分二次服用。以后可根据病情逐渐递增,最大用量一般每日不超过340mg(10粒),分2-4次服用。

不良反应

常见的有震颤、肌强直流涎、静坐不能、吞咽困难等帕金森氏症样反应、但症状通常不严重、减少丁二酸洛沙平用量或加用常规剂量的胆碱等药物治疗可控制、不需要中断治疗可控制。治疗早期或增加剂量时可能会出现轻度嗜睡、但随着用药时间的延长会自行消失。长期治疗或停药时可出现迟发性运动障碍、特别是老年人、高剂量治疗及女性病人。还可见头晕、头痛、失眠、口干、便秘、癫痫样发作和肝功能异常。心动过速、高血压、低血压、ECG变化、皮疹、恶心、呕吐、尿潴留、意识混乱状态、药源性恶性症侯群有过报导。血液等改变、如白细胞减少、罕见。

禁忌

本品禁用于青光眼、癫痫、严重心血管疾病、昏迷、半昏迷、尿潴留及由酒精、巴比妥类和麻醉剂等导致的抑郁状态的患者。对本品及二苯骈氧氮杂7644;类药物过敏者、孕妇、哺乳期妇女及16岁以下儿童禁用。

注意事项

1.丁二酸洛沙平和其他的抗精神病药一样,可能影响人的精神和体力,尤其是治疗的早期。所以在用药期间必须提醒病人在活动时应注意安全,并不要饮酒。
2.对有抽搐史或惊厥史、心血管疾患及排尿不畅者,应慎用。
3.长期应用此药时,应定期作眼底、心电图检查。
4.过量或中毒时,会出现抑郁、低血压、呼吸抑制、意识不清、震颤、抽搐、肾功能衰竭等现象,应及时进行洗胃、透析等对症及支持治疗;禁用中枢兴奋剂;出现低血压时禁用肾上腺素。

贮藏

遮光,密封保存。

规格

13.6mg×30片

证据Evidence

  • 批准文号: 国药准字H20056302
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.